Alisertib-impurities | Pharmaffiliates

Alisertib and its Impurities

Alisertib is an orally available Drug with potential antineoplastic activity. It is a selective inhibitor of aurora A kinase developed by Takeda. Reference standards of Alisertib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for Alisertib Impurities
PA 01 2730000



  • Catalogue No.:PA 01 2730000

  • CAS :


  • Molecular Formula : C27H20ClFN4O4

  • Molecular Weight : 518.93